NASDAQ:MRTX - Mirati Therapeutics Price Target & Analyst Ratings

+0.44 (+0.43 %)
(As of 07/18/2019 01:13 PM ET)
Today's Range
Now: $103.74
50-Day Range
MA: $98.68
52-Week Range
Now: $103.74
Volume15,643 shs
Average Volume548,904 shs
Market Capitalization$3.74 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Mirati Therapeutics (NASDAQ:MRTX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
15 Wall Street analysts have issued ratings and price targets for Mirati Therapeutics in the last 12 months. Their average twelve-month price target is $98.4277, suggesting that the stock has a possible downside of 5.12%. The high price target for MRTX is $132.00 and the low price target for MRTX is $37.00. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.792.692.89
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $98.4277$94.38$68.80$56.4286
Price Target Upside: 5.12% downside2.63% downside7.96% upside9.74% downside

Mirati Therapeutics (NASDAQ:MRTX) Consensus Price Target History

Mirati Therapeutics (NASDAQ:MRTX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/18/2019Deutsche BankInitiated CoverageHold ➝ Hold$86.00LowView Rating Details
7/12/2019JPMorgan Chase & Co.Boost Price TargetNeutral$70.00 ➝ $101.00LowView Rating Details
6/19/2019B. RileyDowngradeBuy ➝ Neutral$60.00 ➝ $92.00MediumView Rating Details
6/7/2019GuggenheimDowngradeBuy ➝ Neutral$95.56MediumView Rating Details
6/5/2019HC WainwrightReiterated RatingBuy ➝ Buy$84.00 ➝ $117.00LowView Rating Details
6/5/2019BarclaysBoost Price TargetOverweight$85.00 ➝ $123.00LowView Rating Details
6/4/2019SunTrust BanksBoost Price TargetBuy$120.00MediumView Rating Details
6/4/2019Piper Jaffray CompaniesBoost Price TargetOverweight$85.00 ➝ $125.00MediumView Rating Details
6/4/2019CowenReiterated RatingBuyHighView Rating Details
6/4/2019Cantor FitzgeraldBoost Price TargetNeutral ➝ Positive$66.00 ➝ $85.00HighView Rating Details
6/4/2019CitigroupUpgradeNeutral ➝ Buy$76.00 ➝ $132.00HighView Rating Details
3/25/2019Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$85.00MediumView Rating Details
3/19/2019OppenheimerReiterated RatingBuyMediumView Rating Details
2/15/2019Svb LeerinkReiterated RatingOutperformHighView Rating Details
11/15/2018Jefferies Financial GroupReiterated RatingHold$37.00HighView Rating Details
11/14/2017Leerink SwannUpgradeMarket Perform ➝ Outperform$9.00N/AView Rating Details
9/19/2017CIBCInitiated CoverageOutperform ➝ Outperform$18.00LowView Rating Details
(Data available from 7/18/2017 forward)
This page was last updated on 7/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel